FABIANI & COMPANY for AFRAXIS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Termination (this page) | Oct 19, 2010 | — | Replaced |
| 3rd Quarter - Termination Amendment | Jan 20, 2011 | — | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Securing federal R&D for treatment of central nervous system diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| JEFFREY STUART WIENER | — |
Defense DEF
Securing federal R&D for treatment of central nervous system diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| JEFFREY STUART WIENER | — |
Pharmacy PHA
Securing federal R&D for treatment of central nervous system diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BARROWS | — |
| JEFFREY STUART WIENER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.